RARA and cancer: The pan-cancer analysis shows that RARA-AS1 is significantly correlated with MSI in five types of cancer, including GBM, CHOL, and ACC, which exhibit a negative correlation, whereas TGCT and THCA exhibit a positive correlation (Fig. 4C).